INTELENCE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Intelence, and what generic alternatives are available?
Intelence is a drug marketed by Janssen R And D and is included in one NDA.
The generic ingredient in INTELENCE is etravirine. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the etravirine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Intelence
A generic version of INTELENCE was approved as etravirine by AMNEAL on June 14th, 2021.
Summary for INTELENCE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 111 |
Clinical Trials: | 14 |
Patent Applications: | 1,995 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for INTELENCE |
What excipients (inactive ingredients) are in INTELENCE? | INTELENCE excipients list |
DailyMed Link: | INTELENCE at DailyMed |


Recent Clinical Trials for INTELENCE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
IRCCS Eugenio Medea | Phase 2 |
University of Rome Tor Vergata | Phase 2 |
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Phase 1 |
Pharmacology for INTELENCE
Anatomical Therapeutic Chemical (ATC) Classes for INTELENCE
US Patents and Regulatory Information for INTELENCE
INTELENCE is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting INTELENCE
PEDIATRIC EXCLUSIVITY
Exclusivity Expiration: See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-003 | Mar 26, 2012 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-001 | Jan 18, 2008 | AB | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-002 | Dec 22, 2010 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for INTELENCE
International Patents for INTELENCE
See the table below for patents covering INTELENCE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 300373 | See Plans and Pricing | |
Poland | 348145 | See Plans and Pricing | |
Portugal | 1129079 | See Plans and Pricing | |
Czech Republic | 20011533 | See Plans and Pricing | |
African Intellectual Property Organization (OAPI) | 11674 | HIV Replication inhibiting pyrimidines. | See Plans and Pricing |
Taiwan | 541305 | See Plans and Pricing | |
Eurasian Patent Organization | 200100536 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for INTELENCE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1002795 | 300373 | Netherlands | See Plans and Pricing | 300373, 20191101, EXPIRES: 20230827 |
1002795 | PA2008016,C1002795 | Lithuania | See Plans and Pricing | PRODUCT NAME: ETRAVIRINUM; REGISTRATION NO/DATE: EU/1/08/468/001 20080828 |
1002795 | CA 2009 00004 | Denmark | See Plans and Pricing | |
1002795 | C01002795/01 | Switzerland | See Plans and Pricing | PRODUCT NAME: ETRAVIRIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58483 13.05.2008 |
1002795 | SZ 5/2009 | Austria | See Plans and Pricing | PRODUCT NAME: ETRAVIRIN UND DESSEN ADDITIONSSALZE |
1002795 | 337 | Finland | See Plans and Pricing | |
1002795 | 91528 | Luxembourg | See Plans and Pricing | 91528, EXPIRES: 20230828 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |